Head-to-head · WeighScore
Hims vs ShedRx
By GLP-1 ScorecardUpdated
Score comparison
ShedRx has the higher recorded score — 87/100 to 75.6/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
Before you choose
Hims does not publish a semaglutide price, so its Hims review sets out what it does disclose, while the ShedRx review explains the conditions attached to ShedRx's figure. The semaglutide cost page compares published rates across the field. Ask Hims for a written total before treating either one as the cheaper choice.
If neither one fits, Hims vs Signos and Immortals vs ShedRx compare each of them with another graded program, and the list of alternatives to Hims ranks the programs closest to Hims on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Hims | ShedRx |
|---|---|---|
| WeighScore | 75.6/100 | 87/100 |
| Grade | C | B+ |
| Site position | #56 | #3 |
| Semaglutide | Varies (branded medication plus separate membership) | $199/mo |
| Tirzepatide | Varies (branded medication plus separate membership) | $299/mo |
| Coverage | Selected states; eligibility varies | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Strengths
- Branded oral and injectable options
- Medication and membership prices presented separately
What to consider
- Required membership adds to advertised medication prices
- Membership does not guarantee a prescription
Site position #3 · B+
Strengths
- Published injection plans plus other formulation and branded prescribing options
- One-month injection prices listed at $199 semaglutide / $299 tirzepatide
- Terms describe monthly coaching and name six possible pharmacy partners
What to consider
- Six- and twelve-month plans specify 24 and 48 weeks of medication
- The 120-day promise has first-time-user and participation requirements and does not cancel a longer plan
- Branded pages display conflicting $99/$125 membership charges, with medication separate
- Actual clinician/pharmacy assignment and the applicable minimum term need confirmation
Featured provider
ShedRx
ShedRx scores 87/100 (B+). Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.